Henry Ji

Henry H.
Ji was the founder of Sorrento Therapeutics, Inc., founded in 2006, where the title held was Director & Chief Scientific Officer.
Dr. Ji is the founder of Sorrento Therapeutics, Inc., founded in 1989, holding the titles of Chairman, President & Chief Executive Officer.
Dr. Ji is the founder of BioVintage, Inc., founded in 2002, holding the title of President.
Dr. Ji was the founder of Stratagene Genomics, Inc., founded in 1997, holding the titles of President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc., Executive Chairman, President & CEO at Semnur Pharmaceuticals, Inc. starting 2026, Chief Executive Officer & Secretary at Semnur, Inc. since 2013, Executive Chairman, President & CEO at Scilex Holding Co. starting 2025, Director at Scilex Pharmaceuticals, Inc. since 2019, and Director at Elsie Biotechnologies Inc.Former jobs include Executive Chairman at Scilex, Inc. from 2019 to 2022, Executive Chairman at Scilex Holding Co. from 2019 to 2023, Director at NantKwest, Inc. from 2014 to 2015, Director-Business Development at Stratagene Corp.
from 1999 to 2001, Managing Director at Hongye SD Group LLC, Director at Celularity, Inc. (United States) from 2017 to 2021, Vice President at CombiMatrix Corp.
from 2001 to 2002, and Secretary & Chief Scientific Officer at Quikbyte Software, Inc. in 2009.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from Fudan University.